A Single-arm Study to Evaluate Safety and Effectiveness of VX-548 for Acute Pain
Pain
About this trial
This is an interventional treatment trial for Pain
Eligibility Criteria
Key Inclusion Criteria: Body mass index (BMI) of greater than or equal to (≥) 18.0 to less than (<) 40.0 kilogram per meter square (kg/m^2) Non-surgical participants with pain of new origin (not related to a prior known condition) that is moderate or severe on the verbal categorical rating scale (VRS) and ≥4 on the numeric pain rating scale (NPRS) Surgical participants reporting pain at the surgical site that is moderate or severe on the VRS and ≥4 on the NPRS Key Exclusion Criteria: Surgical participants: History of previous surgery due to the same condition, except for procedures for which a previous surgery on the contra-lateral limb or organ is allowed History of a prior surgical procedure in the same region of the body that resulted in any perioperative complications or that, in the opinion of the investigator or medical monitor, would preclude participation in the study History of any illness or any clinical condition that, in the opinion of the investigator, might confound the results of the study or pose an additional risk in administering study drug to the participant Other protocol defined Inclusion/Exclusion criteria may apply.
Sites / Locations
- Research Center - Tucson Orthopeadic Institute
- Anaheim Clinical TrialsRecruiting
- Trovare Clinical Research | Bakersfield, CARecruiting
- New Hope Research Development | Tarzana, CARecruiting
- Mart Medical Research Group LLC
- Atlanta Center for Medical Research | Atlanta, GARecruiting
- Duly HealthRecruiting
- Cypress Surgery CenterRecruiting
- OrthoNebraska HospitalRecruiting
- Center for Orthopaedic Reconstruction and ExcellenceRecruiting
- HD Research LLC | First Surgical HospitalRecruiting
- HD Research LLC | Legent Orthopedic HospitalRecruiting
- Futuro Clinical TrialsRecruiting
- South Texas Spine & Surgical HospitalRecruiting
- Renovatio Clinical
- Wasatch Clinical Research
Arms of the Study
Arm 1
Experimental
VX-548
Participants will receive VX-548 every 12 hours (q12h) up to 14 days.